- ICH GCP
- US Clinical Trials Registry
- Search trials
Søk i kliniske studier for: A/Anhui/1/2013 (H7N9)
Totalt 476243 resultater
-
National Institute of Allergy and Infectious Diseases...FullførtInfluensa A-virus, H7N9-subtypeForente stater
-
National Institute of Allergy and Infectious Diseases...Fullført
-
National Institute of Allergy and Infectious Diseases...FullførtInfluensa A-virus, H7N9-subtypeForente stater
-
National Institute of Allergy and Infectious Diseases...FullførtFugleinfluensa | VaksinasjonForente stater
-
National Institute of Allergy and Infectious Diseases...Fullført
-
National Institute of Allergy and Infectious Diseases...Fullført
-
National Institute of Allergy and Infectious Diseases...FullførtInfluensa A-virus, H7N9-subtypeForente stater
-
National Institute of Allergy and Infectious Diseases...Fullført
-
National Institute of Allergy and Infectious Diseases...Fullført
-
National Institute of Allergy and Infectious Diseases...University of RochesterFullførtInfluensa A-virus, H7N9-subtypeForente stater
-
Vaxxas Pty LtdBiomedical Advanced Research and Development AuthorityHar ikke rekruttert ennåH7N9 influensaAustralia
-
GlaxoSmithKlineFullført
-
National Institute of Allergy and Infectious Diseases...FullførtInfluensa | Fugleinfluensa | H1N1 influensaForente stater
-
Hualan Biological Bacterin Co. Ltd.Fullført
-
National Institute of Allergy and Infectious Diseases...Fullført
-
National Institute of Allergy and Infectious Diseases...Fullført
-
Janssen Research & Development, LLCIkke lenger tilgjengeligForhåndsgodkjenning tilgang til Pimodivir for behandling av pasienter med H7N9 influensa A-infeksjonH7N9 undertype av influensa A-virus
-
National Institute of Allergy and Infectious Diseases...Fullført
-
National Institute of Allergy and Infectious Diseases...FullførtInfluensavaksinering | FugleinfluensaForente stater
-
Medigen Vaccine Biologics Corp.Fullført
-
National Institute of Allergy and Infectious Diseases...FullførtInfluensavaksinering | FugleinfluensaForente stater
-
Butantan InstituteFullførtInfluensa | H7N9 influensaBrasil
-
National Institute of Allergy and Infectious Diseases...Fullført
-
Shanghai Institute Of Biological ProductsHenan Center for Disease Control and PreventionUkjent
-
NovavaxDepartment of Health and Human ServicesFullført
-
Sanofi Pasteur, a Sanofi CompanyFullførtInfluensaForente stater
-
Novartis VaccinesFullførtH7N9 influensaForente stater
-
American Thrombosis and Hemostasis NetworkBayer; Shire; CSL Behring; Bioverativ Therapeutics Inc.Fullført
-
Shanghai Institute Of Biological ProductsUkjent
-
Sanofi Pasteur, a Sanofi CompanyFullført
-
University of OxfordFullførtParkinsons sykdomStorbritannia
-
Research Institute of Influenza, RussiaWorld Health Organization; Institute of Experimental Medicine, RussiaFullført
-
Washington University School of MedicineEunice Kennedy Shriver National Institute of Child Health and Human Development...Aktiv, ikke rekrutterendeA. Longitudinell kohort n=400 | B. Lavere risiko (n=45) og høyere risiko (n=105) Randomisert 2:1 til PERCCS-intervensjonForente stater
-
Wilfrid Laurier UniversityFullførtAngst | BeskjedenhetCanada
-
Heidelberg Engineering GmbHFullført
-
GlaxoSmithKlineFullført
-
National Institute of Allergy and Infectious Diseases...FullførtHIV-infeksjoner
-
Research Institute of Influenza, RussiaWorld Health Organization; Institute of Experimental Medicine, Russia; Joint...Ukjent
-
Bursa Yüksek İhtisas Education and Research HospitalFullførtFibromyalgi | Behcets sykdomTyrkia
-
Johnson & Johnson Vision Care, Inc.FullførtSynsskarphetForente stater, Hong Kong
-
Finnish Institute for Health and WelfareKarolinska Institutet; Peking University; Fudan University; Chongqing Medical... og andre samarbeidspartnereFullført
-
Johnson & Johnson Vision Care, Inc.Fullført
-
Coopervision, Inc.Fullført
-
Coopervision, Inc.Fullført
-
Lene HolmvangFullførtKoronararteriesykdom | Perkutan koronar intervensjon | Akutte koronare syndromerDanmark
-
Inter-American Development BankFullført
-
Coopervision, Inc.Fullført
-
Alcon ResearchFullført
-
DynPort Vaccine Company LLC, A GDIT CompanyFullførtREKOMBINANT BOTULINUM-VAKSINE A/BForente stater